Zobrazeno 1 - 5
of 5
pro vyhledávání: '"S. E. Nikoulina"'
Publikováno v:
Diabetes. 46:1230-1234
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dac543b38bb830ab871a8293398c2358
https://doi.org/10.2337/diabetes.46.7.1230
https://doi.org/10.2337/diabetes.46.7.1230
Publikováno v:
Diabetes. 46:1017-1024
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a2899afcb477d9464d1968e8db20217
https://doi.org/10.2337/diabetes.46.6.1017
https://doi.org/10.2337/diabetes.46.6.1017
Publikováno v:
Diabetes. 45:400-407
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03131e2288426a2e35983e2799b1ef70
https://doi.org/10.2337/diabetes.45.4.400
https://doi.org/10.2337/diabetes.45.4.400
Autor:
K S, Park, T P, Ciaraldi, K, Lindgren, L, Abrams-Carter, S, Mudaliar, S E, Nikoulina, S R, Tufari, J H, Veerkamp, A, Vidal-Puig, R R, Henry
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(8)
Troglitazone, besides improving insulin action in insulin-resistant subjects, is also a specific ligand for the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARgamma). To determine whether troglitazone might enhance insulin act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5b5674b37ce39c9a36f51f30c58f9a1b
https://pubmed.ncbi.nlm.nih.gov/9709955
https://pubmed.ncbi.nlm.nih.gov/9709955
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(5)
To determine the effects of troglitazone on abnormal skeletal muscle glucose metabolism, muscle cultures from type II diabetic patients were grown for 4-6 weeks and then fused for 4 days either without or with troglitazone (1-5 micrograms/mL; chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c622ef0159937b8ac667f5e9bac33f96
https://pubmed.ncbi.nlm.nih.gov/9589670
https://pubmed.ncbi.nlm.nih.gov/9589670